Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9430 | 1088 | 26.8 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
266 | 18634 | CHORDOMA//ANEURYSMAL BONE CYST//OSTEOID OSTEOMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SOFT TISSUES NEOPLASMS | Author keyword | 15 | 49% | 2% | 22 |
2 | BONE NEOPLASMS MR | Author keyword | 8 | 46% | 1% | 13 |
3 | MUSCLES NEOPLASMS | Author keyword | 6 | 48% | 1% | 10 |
4 | SOFT TISSUES MR STUDIES | Author keyword | 6 | 80% | 0% | 4 |
5 | SOFT TISSUES MR | Author keyword | 4 | 40% | 1% | 8 |
6 | LODWICK CLASSIFICATION | Author keyword | 3 | 60% | 0% | 3 |
7 | MUSCULOSKELETAL TUMORS | Author keyword | 3 | 30% | 1% | 7 |
8 | BONE NEOPLASMS DIAGNOSIS | Author keyword | 2 | 28% | 1% | 7 |
9 | MALIGNANT BONE AND SOFT TISSUE TUMORS | Author keyword | 2 | 67% | 0% | 2 |
10 | TUMORLIKE LESIONS | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MUSCULOSKELETAL TUMORS | 72 | 48% | 10% | 109 |
2 | MUSCULOSKELETAL NEOPLASMS | 24 | 49% | 3% | 36 |
3 | SOLITARY BONE LESIONS | 21 | 90% | 1% | 9 |
4 | NEOADJUVANT THERAPY RESPONSE | 19 | 68% | 2% | 17 |
5 | FIRST PASS IMAGES | 15 | 73% | 1% | 11 |
6 | INTRAOSSEOUS EXTENT | 12 | 75% | 1% | 9 |
7 | PEDIATRIC BONE SARCOMAS | 12 | 86% | 1% | 6 |
8 | PRIMARY BONE TUMORS | 9 | 24% | 3% | 35 |
9 | OSTEOSARCOMA RESPONSE | 7 | 57% | 1% | 8 |
10 | EWING SARCOMA | 7 | 16% | 4% | 39 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Diagnostic accuracy of (18) F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis | 2012 | 14 | 16 | 88% |
The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma | 2013 | 9 | 26 | 58% |
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis | 2004 | 108 | 46 | 59% |
Radiography in the Initial Diagnosis of Primary Bone Tumors | 2013 | 3 | 10 | 80% |
FDG PET/CT of Primary Bone Tumors | 2014 | 1 | 50 | 72% |
Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing's sarcoma: review of current imaging modalities | 1998 | 60 | 56 | 68% |
Magnetic resonance imaging of soft tissue tumors | 2000 | 55 | 21 | 81% |
Utilization of positron emission tomography in the management of patients with sarcoma | 2009 | 22 | 60 | 60% |
Bone tumors and tumorlike conditions: Analysis with conventional radiography | 2008 | 25 | 26 | 54% |
Soft-Tissue Masses: Optimal Imaging Protocol and Reporting | 2013 | 5 | 8 | 38% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ABT OSTEORADIOL | 1 | 50% | 0.2% | 2 |
2 | COMPREHENS NEUROFIBROMATOSIS | 1 | 50% | 0.2% | 2 |
3 | ST THOMAS SOFT TISSUE TUMOUR UNIT | 1 | 100% | 0.2% | 2 |
4 | MR SPECT | 1 | 40% | 0.2% | 2 |
5 | UNIT RADIOL MED IMAGING | 1 | 40% | 0.2% | 2 |
6 | GUYS ST THOMAS CLIN PET | 1 | 27% | 0.3% | 3 |
7 | DIAGNOST IMAGING 332 N LAUDERDALE POB 318 | 1 | 33% | 0.2% | 2 |
8 | BONE SOFT TISSUE TUMOR SURG | 1 | 50% | 0.1% | 1 |
9 | DIAGNOST IMAGING POB 318 332 N LAUDERDALE | 1 | 50% | 0.1% | 1 |
10 | DIAGNOST ONCOL THER Y | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000148834 | OSTEOSARCOMA//METASTATIC OSTEOSARCOMA//SEZ CHEMIOTER IA |
2 | 0.0000141214 | BONE MARROW SCINTIGRAPHY//WHOLE BODY MRI//BONE MARROW NEOPLASMS |
3 | 0.0000112629 | SOFT TISSUE SARCOMA//RETROPERITONEAL SARCOMA//RETROPERITONEAL SARCOMAS |
4 | 0.0000105541 | VERTEBRAL BIOPSY//BONES BIOPSY//BONE CYTOLOGY |
5 | 0.0000092515 | GEODE//RADIOLOGICAL INVOLVEMENT//SUBCHONDRAL CYSTS |
6 | 0.0000091800 | JAFFE CAMPANACCI SYNDROME//BENIGN FIBROUS HISTIOCYTOMA//NON OSSIFYING FIBROMA |
7 | 0.0000080456 | CHONDROSARCOMA//MESENCHYMAL CHONDROSARCOMA//EXTRASKELETAL MYXOID CHONDROSARCOMA |
8 | 0.0000077133 | BIZARRE PAROSTEAL OSTEOCHONDROMATOUS PROLIFERATION//PAROSTEAL OSTEOSARCOMA//NORAS LESION |
9 | 0.0000072380 | ELASTOFIBROMA//ELASTOFIBROMA DORSI//PERISCAPULAR MASS |
10 | 0.0000065781 | ROTATIONPLASTY//HEMIPELVECTOMY//LIMB SALVAGE |